- Home
- EVMN vs PDLB Comparison
EVMN vs PDLB Comparison
Compare EVMN & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVMN | PDLB |
|---|---|---|
| Founded | 2020 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 405.2M | 481.1M |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EVMN | PDLB |
|---|---|---|
| Price | $12.48 | $19.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $43.88 | N/A |
| AVG Volume (30 Days) | ★ 445.8K | 63.4K |
| Earning Date | 06-11-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 75.23 | ★ 160.87 |
| EPS | N/A | ★ 0.71 |
| Revenue | ★ $13,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $28.56 |
| Revenue Growth | ★ 85.71 | N/A |
| 52 Week Low | $10.47 | $13.91 |
| 52 Week High | $33.20 | $21.10 |
Technical Indicators
Market Signals| Indicator | EVMN | PDLB |
|---|---|---|
| Relative Strength Index (RSI) | 40.78 | 45.40 |
| Support Level | $12.07 | $19.61 |
| Resistance Level | $15.06 | $20.81 |
| Average True Range (ATR) | 0.70 | 0.42 |
| MACD | -0.10 | -0.06 |
| Stochastic Oscillator | 4.36 | 18.22 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About PDLB Ponce Financial Group Inc.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.